Acceptability of oral dimethandrolone undecanoate in a 28-day placebo-controlled trial of a hormonal male contraceptive prototype

OBJECTIVE: To determine men’s satisfaction with and acceptability of a once-daily, oral regimen of dimethandrolone undecanoate (DMAU) versus placebo when used for 28 days. STUDY DESIGN: After a Phase I double-blind, randomized, placebo-controlled, dose-escalating trial of oral DMAU for 28-days, 57 h...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Contraception
Päätekijät: Nguyen, Brian T., Farrant, Maritza T, Anawalt, Bradley D., Yuen, Fiona, Thirumalai, Arthi, Amory, John K, Swerdloff, Ronald S., Bremner, William J, Liu, Peter Y., Blithe, Diana L., Page, Stephanie T., Wang, Christina
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7287214/
https://ncbi.nlm.nih.gov/pubmed/32298717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2020.04.006
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia